AVCT21 Sep 2018 08:44
Well I'm never quite sure how to take these events, will it change the SP? I doubt by very much, may see a quick lift but then drop back probably.
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that Alastair Smith, CEO of Avacta, will be presenting at an investor evening hosted by Turner Pope Investments (TPI) Ltd. TPI acted as a joint agent in the recent £11.6m placing by Avacta Group plc.
The event will be held on 1st October, London, EC2 and will commence at 5.00pm. To Register your interest, please email info@turnerpope.com or call 0203 621 4121.